CXC Chemokine-Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response
Hongdan Chen1,2,3, Yinde Huang1, Juntong Wu1,2
1Department of Breast and Thyroid Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China.
Abstract:
Aberrant tumor vasculature drives hypoxia, immune exclusion, and therapeutic resistance. However, current vascular normalization strategies remain primarily VEGF-centered, relying on morphological and perfusion metrics with limited molecular readouts to monitor vessel function. This highlights the need for alternative frameworks to identify therapeutic windows and enhance vascular-immune strategies. Here, we introduce a chemokine-centered perspective that positions the CXC chemokine network as a dynamic regulator of vascular functionality. We highlight three core mechanistic dimensions: bidirectionality, temporal dynamics, and tissue specificity, and further emphasize the functional synergy emerging from their network-level interactions. Building on these features, we propose the functional vascular normalization score (FVNS) and the chemokine-guided vascular normalization window (VNW) as molecular tools for real-time vascular assessment and therapeutic stratification. Finally, we outline CXC-targeted strategies, including CXCR2/CXCR4 blockade, CXCL9/10/11 augmentation, and spatiotemporally controlled delivery platforms, which may extend and personalize the VNW. This chemokine-focused paradigm provides a functional and implementable approach for the integration of vascular normalization and immune modulation in cancer therapy.
Insights
This study introduces a novel chemokine-centered approach to cancer therapy, moving beyond VEGF. It proposes new molecular tools to assess tumor vasculature and guide treatment for better vascular normalization and immune modulation.
Area of Science:
- Oncology
- Immunology
- Vascular Biology
Background:
- Aberrant tumor vasculature contributes to cancer progression, immune evasion, and treatment resistance.
- Current vascular normalization strategies, mainly VEGF-focused, lack molecular insights into vessel function.
- There is a critical need for advanced methods to assess therapeutic windows and improve vascular-immune interactions.
Purpose of the Study:
- To introduce a chemokine-centered framework for understanding and manipulating tumor vascular functionality.
- To propose novel molecular tools for real-time vascular assessment and therapeutic stratification.
- To outline targeted CXC chemokine strategies for enhanced cancer therapy.
Main Methods:
- Developed a chemokine-centered perspective focusing on the CXC chemokine network.
- Analyzed mechanistic dimensions: bidirectionality, temporal dynamics, and tissue specificity.
- Proposed the functional vascular normalization score (FVNS) and the chemokine-guided vascular normalization window (VNW).
Main Results:
- The CXC chemokine network dynamically regulates vascular functionality through interconnected mechanisms.
- FVNS and VNW offer molecular tools for real-time vascular assessment and treatment planning.
- CXC-targeted strategies like CXCR2/CXCR4 blockade and CXCL9/10/11 augmentation show therapeutic potential.
Conclusions:
- A chemokine-focused paradigm offers a functional and implementable approach to integrate vascular normalization and immune modulation in cancer treatment.
- This framework enables personalized therapeutic strategies by extending and refining the VNW.
- The proposed tools and strategies can enhance the efficacy of cancer therapies by targeting tumor vasculature and immune responses.
More Related Videos
Related Concept Videos
Inflammatory Response I: Vascular and Cellular
Seedless Vascular Plants
Therapeutic Index
Introduction to Nuclear Reprogramming
Methods of Nuclear Reprogramming
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...


